FDA’s Quality Management Maturity Program
In an era where medical devices and pharmaceuticals are becoming increasingly complex, ensuring their safety and efficacy is paramount. The FDA’s Quality Management Maturity (QMM) Program represents a significant step forward in achieving this goal. By focusing on the quality management systems of manufacturers, the QMM Program aims to enhance the overall safety and effectiveness […]
European Commission’s Guidance for Joint Clinical Assessments
In an effort to streamline and enhance the evaluation of health technologies across Europe, the European Commission has released a comprehensive guide focused on the validity of studies for joint clinical assessments (JCAs). This initiative, rolled out under the EU Health Technology Assessment Regulation (HTAR), represents a significant step toward harmonizing the assessment of new […]
The Canadian Artificial Intelligence and Data Act
In an era where artificial intelligence (AI) is rapidly transforming industries and societal norms, Canada has taken a significant step forward by introducing the Artificial Intelligence and Data Act (AIDA). This landmark legislation aims to establish a robust framework for the development and use of AI technologies while ensuring ethical standards, transparency, and accountability. What […]
